BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37480572)

  • 21. The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.
    Yahagi M; Okabayashi K; Hasegawa H; Tsuruta M; Kitagawa Y
    J Gastrointest Surg; 2016 Mar; 20(3):648-55. PubMed ID: 26573851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.
    Imperial R; Ahmed Z; Toor OM; Erdoğan C; Khaliq A; Case P; Case J; Kennedy K; Cummings LS; Melton N; Raza S; Diri B; Mohammad R; El-Rayes B; Pluard T; Hussain A; Subramanian J; Masood A
    Mol Cancer; 2018 Dec; 17(1):177. PubMed ID: 30577807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.
    Gholamalizadeh H; Zafari N; Velayati M; Fiuji H; Maftooh M; Ghorbani E; Hassanian SM; Khazaei M; Ferns GA; Nazari E; Avan A
    Clin Exp Med; 2023 Dec; 23(8):4369-4383. PubMed ID: 37405571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular heterogeneity of guanine nucleotide binding-protein γ subunit 4 in left- and right-sided colon cancer.
    Song J; Yang J; Lin R; Cai X; Zheng L; Chen Y
    Oncol Lett; 2020 Dec; 20(6):334. PubMed ID: 33123245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.
    Azar I; Al Masalmeh N; Esfandiarifard S; Virk G; Kiwan W; Frank Shields A; Mehdi S; Philip PA
    Cancer Med; 2021 May; 10(9):2987-2995. PubMed ID: 33797856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of primary colorectal Cancer location on the KRAS status and its prognostic value.
    Xie MZ; Li JL; Cai ZM; Li KZ; Hu BL
    BMC Gastroenterol; 2019 Mar; 19(1):46. PubMed ID: 30917791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer.
    Song K; Zhao W; Wang W; Zhang N; Wang K; Chang Z
    Cancer Sci; 2018 Jun; 109(6):1939-1948. PubMed ID: 29700901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China.
    Abasse Kassim S; Tang W; Abbas M; Wu S; Meng Q; Zhang C; Li X; Chen R
    Cancer Epidemiol; 2019 Oct; 62():101565. PubMed ID: 31323459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Better survival of right-sided than left-sided stage II colon cancer: a propensity scores matching analysis based on SEER database.
    Wang S; Xu X; Guan J; Huo R; Liu M; Jiang C; Wang W
    Turk J Gastroenterol; 2020 Nov; 31(11):805-813. PubMed ID: 33361044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study.
    Hamfjord J; Myklebust TÅ; Larsen IK; Kure EH; Glimelius B; Guren TK; Tveit KM; Guren MG
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):342-351. PubMed ID: 34853022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection.
    Peng J; Li C; Wang F; Zhang H; Xiao W; Li H; Lu Z; Pan Z; Wu X; Zhang R
    Cancer Manag Res; 2018; 10():2095-2103. PubMed ID: 30140160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers.
    Liu X; Xu X; Wu Z; Shan Q; Wang Z; Wu Z; Ding X; Huang W; Wang Z
    Front Immunol; 2022; 13():961350. PubMed ID: 36172359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinicopathological and survival features of right and left colon cancers.
    Helvaci K; Eraslan E; Yildiz F; Tufan G; Demirci U; Berna Oksuzoglu O; Yalcintas Arslan U
    J BUON; 2019; 24(5):1845-1851. PubMed ID: 31786846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in Cancer-Specific Mortality of Right- Versus Left-Sided Colon Adenocarcinoma: A Surveillance, Epidemiology, and End Results Database Analysis.
    Wang C; Wainberg ZA; Raldow A; Lee P
    JCO Clin Cancer Inform; 2017 Nov; 1():1-9. PubMed ID: 30657397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological differences and correlations between right and left colon cancer.
    Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
    World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer.
    Hu W; Yang Y; Li X; Huang M; Xu F; Ge W; Zhang S; Zheng S
    Mol Cancer Res; 2018 Mar; 16(3):476-485. PubMed ID: 29187560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinicopathological features and
    Xue X; Li X; Pan Z; Zhao L; Ding Y
    Int J Clin Exp Pathol; 2017; 10(11):11353-11359. PubMed ID: 31966490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of genomic alterations in Chinese colorectal cancer patients.
    Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
    Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.